The ATM gene and ataxia telangiectasia

Anticancer Research

Volumn 28, Issue 1 B, 2008, Pages 401-405

  Mavrou, Ariadni ^a   Tsangaris, George Th ^b   Roma, Eleftheria ^a   Kolialexi, Aggeliki ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Ataxia telangiectasia; ATM gene; Cancer susceptibility; Molecular genetics; Review

Indexed keywords

ALPHA FETOPROTEIN; ATM PROTEIN; PROTEIN P53;

ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL CYCLE; CHROMOSOME ABERRATION; CLINICAL FEATURE; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENETIC DAMAGE; HUMAN; NERVE DEGENERATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 40549091949     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. McKinnon PJ: ATM and Ataxia telangiactasia. EMBO 58: 772-776, 2004.
2. Chun HH and Gatti RA: Ataxia telangiectasia, an evolving phenotype. DNA Repair 3: 1187-1196, 2004.
3. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA and Lederman HM: Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 144: 505-511, 2004.
4. Farina L, Uggetti C, Ottolini A, Martelli A, Bergamaschi R, Sibilla L, Zappoli F, Egitto MG and Lanzi G: Ataxia telangiectasia: MR and CT finding. J Comput Assist Tomogr 18: 724-727, 1994.
5. Lavin MF, Gueven N, Bottle S and Gatti RA: Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. British Med Bull 81/82: 129-147, 2007.
6. Ball LG and Xiao W: Molecular basis of ataxia telangiectasia and related diseases. Acta Parmacologica Sinica 26: 897-907, 2005.
7. Smith GCM, Cary RB, Lakin ND, Hann BC, Teo SH, Chen DJ and Jackson SP: Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Nat Acad Sci USA 96: 11134-11139, 1999.
8. Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bel S, Udar N, Borresen-Dale AL, Chessa L, Bernatowska-Matuszkiewicz E, Porras O, Watanabe M, Junker A, Concannon P and Gatti RA: Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62: 86-97, 1998.
9. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
10. Boultwood J: Ataxia telangiectasia gene mutations in leukemia and lymphoma. J Clin Pathol 54: 512-516, 2001.
11. Yu G, Zhu M, Zhu Z, Ni C, Zheng J and Li F: Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array. Pancreas 28: 421-426, 2004.
12. Hall J: The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Cancer Letters 227: 105-114, 2005.
13. Concannon P and Gattie RA: Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mut 10: 100-107, 1997.
14. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S and Gueven N: ATM signalling and genomic instability in response to DNA damage. Mutation Research 569: 123-132, 2005.
15. Li A and Swift M: Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 92: 70-77, 2000.
16. Wright J, Teraoka S, Onengut S, Tolun A, Gatti RA, Ochs HD and Concannon P: A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. Am J Hum Genet 59: 839-846, 1996.
17. Khanna KK: Cancer Risk and the ATM Gene: a Continuing Debate. J Nat Canc Instit 92: 795-802, 2000.
18. Morrison C, Sonoda E, Takao N, Shinohara A, Yamamoto K and Takeda S: The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO 19: 463-471, 2000.
19. Becker-Catania, SG, Chen G, Hwang MJ, Wang Z, Sun X, Sanal O, Bernatowska-Matuszkiewicz E, Chessa L, Lee EyHP and Gatti RA: Ataxia-Telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab 70: 122-133, 2000.
20. Matei IR, Guidos CJ and Danska JS: ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis : the DSB connection. Immun Rev 209: 142-158, 2006.
21. Wood RD, Mitchell M and Lindahl T: Human DNA repair genes, 2005. Mutat Res 577: 275-283, 2005.
22. Herbig U, Chen BP, Chen DJ and Sedivy JM: Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21(CIPI) but not p16(INK4A). Mol Cell 14: 501-513, 2004.
23. Metcalfe JA, Parkhill J, Campbell L, Stacey M, Biggs P, Byrd PJ and Taylor AM: Accelerated telomere shortening in ataxia telangiectasia.Nat Genet 13: 350-353, 1996.
24. Gumy-Pause F, Wacker P and Sappino AP: ATM gene and lymphoid malignancies. Leukemia 18: 238-242, 2004.
25. Geoffroy-Perez B, Janin N, Osian K, Lauge A, Croquette MF, Griscelli C, Debre M, Bressac-de-Paillerets B, Aurias A Stoppa-Lyonnet D. and Andrieu N: Cancer risk in heterozygotes for Ataxia-Telangiectasia. Int J Cancer 93: 288-293, 2001
26. Barnes DE, Stamp G, Rosewell I, Denzel A and Lindahl T: Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr Biol 8: 1395-1398, 1998.
27. Lavin M: Role of the ataxia-telangiectasia gene (ATM) in breast cancer. BMJ 317: 486-487, 1998.
28. Rao KS: Mechanisms of disease: DNA repair defects and neurological disease. Nature clinical practice. Neurology 3: 162-172, 2007.
29. Stewart GS, Maser RS, Stankovit T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH and Taylor AM: The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99: 577-587, 1999.
30. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanová E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P and Reis A: Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93: 467-476, 1998.